<!--suppress ALL -->
<h3>AGA clinical guidelines help you practice evidence-based medicine.</h3>

<h2>&nbsp;</h2>

<p>AGA utilizes the GRADE system (Grades of Recommendation Assessment, Development and Evaluation). <a href="/guidelines/guidelines-policies" target="_top">Learn about GRADE</a>. Our guidelines are regularly reviewed for accuracy. Learn about t<a href="/guidelines/guidelines-policies#Updating" target="_top">he update process.</a>&nbsp;AGA endorses guidelines that meet the IOM&#39;s rigorous criteria for evidence-based clinical recommendations. <a href="/guidelines/guidelines-policies#Endorsing" target="_top">Endorsement criteria and methods.</a></p>

<p><a class="show-all-accordion" href="#" target="_top">Expand All</a></p>

<div class="accordion">
    <div class="short"><img src="/patient-care/conditions-diseases/Colorectal_Cancer.jpg" style="width: 128px; height: 128px;" />
        <h2>Colorectal Cancer</h2>

        <p>In the U.S., colorectal cancer (CRC) is the third most common cancer diagnosed among men and women and the second leading cause of death from cancer. CRC largely can be prevented by the detection and removal of adenomatous polyps. AGA offers a broad portfolio of guidelines, decision support tools and standards to support high-quality patient care.</p>
    </div>

    <div class="long">
        <div>
            <h3>Screening for Early Detection</h3>

            <p>Colorectal Cancer Screening and Surveillance for Early Detection</p>

            <p><a href="/guidelines/2008/02/13/screening-for-early-detection" target="_top">Guideline</a> | <a href="http://campaigns.gastro.org/algorithms/crc/early-detection/" target="_top">Clinical Decision Support Tool</a></p>
        </div>

        <div>
            <h3>Colonoscopy After Cancer Resection</h3>

            <p>Colonoscopy Surveillance After Cancer Resection</p>

            <p><a href="/guidelines/2014/03/05/colonoscopy-after-cancer-resection" target="_top">Guideline</a> | <a href="http://campaigns.gastro.org/algorithms/crc/resection/" target="_top">Clinical Decision Support Tool</a></p>
        </div>

        <div>
            <h3>Colonoscopy After Polypectomy</h3>

            <p>Colonoscopy Surveillance After Screening and Polypectomy</p>

            <p><a href="/guidelines/2012/07/03/colonoscopy-after-polypectomy" target="_top">Guideline</a> | <a href="http://campaigns.gastro.org/algorithms/crc/surveillance/" target="_top">Clinical Decision Support Tool</a></p>
        </div>

        <div>
            <h3>Lynch Syndrome</h3>

            <p>Guidelines on Genetic Evaluation and Management of Lynch Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer</p>

            <p><a href="/guidelines/2015/03/26/lynch-syndrome" target="_top">Guideline</a></p>
        </div>

        <div>
            <h3>Bowel Cleansing</h3>

            <p>Optimizing Adequacy of Bowel Cleansing for Colonoscopy: Recommendations From the US Multi-Society Task Force on Colorectal Cancer</p>

            <p><a href="/guidelines/2014/07/02/bowel-cleansing-for-colonoscopy" target="_top">Guideline</a></p>
        </div>

        <div>
            <h3>For IBD Patients</h3>

            <p>Colorectal Neoplasia in Inflammatory Bowel Disease, Diagnosis and Management</p>

            <p><a href="/guidelines/2014/03/04/for-ibd-patients" target="_top">Guideline</a> |<a href="http://www.gastrojournal.org/article/S0016-5085(09)02200-8/fulltext" target="_top"> Technical Review</a></p>

            <p>&nbsp;</p>
        </div>

        <div>
            <h3>CT Colongraphy</h3>

            <p>CT Colonography Standards</p>

            <p><a href="/guidelines/2007/09/01/ct-colongraphy" target="_top">Guideline</a></p>
        </div>

        <div>
            <h3>AGA Guideline on the Diagnosis and Management of Lynch Syndrome</h3>

            <p>Expected September 2015</p>

            <p>&nbsp;</p>
        </div>
    </div>

    <!-- *-------===== IBD Start =====-------* -->

    <div class="short"><img src="/patient-care/conditions-diseases/IBD.jpg" style="width: 128px; height: 128px;" />
        <h2>IBD</h2>

        <p>The two inflammatory bowel diseases (IBD) are Crohn&rsquo;s disease and ulcerative colitis (UC). Most care for these chronic diseases occurs in the outpatient setting, with hospitalizations reserved for complications that might require surgery. AGA offers a guideline on drug therapy and decision support tools for patient management.</p>
    </div>

    <div class="long">
        <div>
            <h3>Crohn&rsquo;s Disease</h3>

            <p>Guidelines for the Identification, Assessment and Initial Medical Treatment in Crohn&rsquo;s Disease</p>

            <p><a href="http://campaigns.gastro.org/algorithms/IBDCarePathway/" target="_top">Clinical Decision Support Tool</a></p>
        </div>

        <div>
            <h3>Managing CRC Risk</h3>

            <p>Colorectal Neoplasia in Inflammatory Bowel Disease, Diagnosis and Management</p>

            <p><a href="/guidelines/2015/04/16/managing-crc-risk" target="_top">Guideline</a> | <a href="http://www.gastrojournal.org/article/S0016-5085(09)02200-8/fulltext" target="_top">Technical Review</a></p>
        </div>

        <div>
            <h3>Drug Therapy for Crohn&rsquo;s</h3>

            <p>Inflammatory Crohn&rsquo;s Disease: Thiopurines, Methotrexate and Anti-TNF-&alpha; Biologic Drugs for Induction and Maintenance of Remission</p>

            <p><a href="/guidelines/2014/03/04/drug-therapy-for-crohn-s" target="_top">Guideline</a> | <a href="http://download.journals.elsevierhealth.com/pdfs/journals/0016-5085/PIIS0016508513015205.pdf" target="_top">Technical Review</a> | <a href="http://campaigns.gastro.org/algorithms/crohns/" target="_top">Clinical Decision Support Tool</a></p>
        </div>

        <div>
            <h3>Microsopic Colitis</h3>

            <p>Expected December 2015</p>

            <p>&nbsp;</p>
        </div>

        <div>
            <h3>Management of Crohn&#39;s Disease After Surgery</h3>

            <p>Expected Fall 2016</p>

            <p>&nbsp;</p>
        </div>
    </div>
    <!-- *-------===== Liver Diseases Start =====-------* -->

    <div class="short"><img src="/patient-care/conditions-diseases/Hep_C.jpg" style="width: 128px; height: 128px;" />
        <h2>Liver Diseases</h2>

        <p>AGA&rsquo;s liver disease resources include guidelines and decision tools for hepatitis C screening and evaluation, how to handle hepatitis B reactivation during immunosuppressive therapy and managing NAFLD patients.</p>
    </div>

    <div class="long">
        <div>
            <h3>Hepatitis C</h3>

            <p>Hepatitis C Screening and Evaluation</p>

            <p><a href="http://campaigns.gastro.org/algorithms/hcv/" target="_top">Clinical Decision Support Tool</a></p>
        </div>

        <div>
            <h3>Hepatitis B Reactivation</h3>

            <p>Hepatitis B Reactivation During Immunosuppressive Drug Therapy</p>

            <p><a href="/guidelines/2014/10/31/hepatitis-b-reactivation" target="_top">Guideline</a> | <a href="http://www.gastrojournal.org/article/S0016-5085(14)01330-4/fulltext" target="_top">Technical Review</a> | <a href="http://campaigns.gastro.org/algorithms/HBVr/" target="_top">Clinical Decision Support Tool</a></p>
        </div>

        <div>
            <h3>Nonalcoholic Fatty Liver Disease</h3>

            <p>Nonalcoholic Fatty Liver Disease</p>

            <p><a href="/guidelines/2012/05/21/nonalcoholic-fatty-liver-disease" target="_top">Guideline</a></p>
        </div>

        <div>
            <h3>Acute Liver Failure</h3>

            <p>Expected fall 2015</p>

            <p>&nbsp;</p>
        </div>

        <div>
            <h3>Elastography to Evaluate Liver Fibrosis</h3>

            <p>Expected Fall 2016</p>

            <p>&nbsp;</p>
        </div>
    </div>
    <!-- *-------===== Esophageal Diseases Start =====-------* -->

    <div class="short"><img src="/patient-care/conditions-diseases/GERD.jpg" style="width: 128px; height: 128px;" />
        <h2>Esophageal Diseases</h2>

        <p>Two of the most common esophageal diseases seen by gastroenterologists are Barrett&rsquo;s esophagus and GERD. AGA resources focus on major clinical issues encountered by physicians who treat patients with Barrett&#39;s esophagus and the general issues related to managing GERD.</p>
    </div>

    <div class="long">
        <div>
            <h3>Barrett&#39;s Esophagus</h3>

            <p>Barrett&#39;s Esophagus</p>

            <p><a href="/guidelines/2014/03/05/barrett-s-esophagus" target="_top">Guideline</a> | <a href="http://www.gastrojournal.org/article/S0016-5085(11)00085-0/fulltext" target="_top">Technical Review</a></p>
        </div>

        <div>
            <h3>Gastroesophageal Reflux Disease (GERD)</h3>

            <p>Gastroesophageal Reflux Disease (GERD)</p>

            <p><a href="/guidelines/2008/09/16/gastroesophageal-reflux-disease-gerd" target="_top">Guideline</a> | <a href="http://www.gastrojournal.org/article/S0016-5085(08)01605-3/fulltext" target="_top">Technical Review</a></p>
        </div>
    </div>
    <!-- *-------===== Sedation Start =====-------* -->

    <div class="short"><img src="/patient-care/procedures/Sedation.jpg" style="width: 128px; height: 128px;" />
        <h2>Sedation</h2>

        <p>Sedation and analgesia are considered by many gastroenterologists to be an integral component of the endoscopic examination. Sedation is intended primarily to reduce a patient&rsquo;s anxiety and discomfort, consequently improving their tolerability and satisfaction for the procedure.</p>
    </div>

    <div class="long">
        <div>
            <h3>Endoscopic Sedation</h3>

            <p>Endoscopic sedation</p>

            <p><a href="/guidelines/2014/03/04/endoscopic-sedation" target="_top">Guideline</a></p>
        </div>
    </div>
    <!-- *-------===== Pancreatic Disorders Start =====-------* -->

    <div class="short"><img src="/patient-care/conditions-diseases/Pancreatitis.jpg" style="width: 128px; height: 128px;" />
        <h2>Pancreatic Disorders</h2>

        <p>Acute pancreatitis is a disease of increasing annual incidence and one that produces significant morbidity and mortality and consumes enormous health care resources. AGA provides guidelines to guide clinicians in the management of patients with both mild and severe acute pancreatitis.</p>
    </div>

    <div class="long">
        <div>
            <h3>Acute Pancreatitis</h3>

            <p>Acute Pancreatitis</p>

            <p><a href="/guidelines/2014/03/04/acute-pancreatitis" target="_top">Guideline</a> | <a href="http://www.gastrojournal.org/article/S0016-5085(07)00591-4/fulltext" target="_top">Technical Review</a></p>
        </div>

        <div>
            <h3>Pancreatic Cysts</h3>

            <p>Pancreatic Cysts</p>

            <p><a href="/guidelines/2015/5/29/pancreatic-cysts" target="_top">Guideline</a> | <a href="http://www.gastrojournal.org/article/S0016-5085(15)00099-2/abstract" target="_top">Technical Review</a></p>
        </div>
    </div>
    <!-- *-------===== Irritable Bowel Syndrome Start =====-------* -->

    <div class="short"><img src="/patient-care/conditions-diseases/IBS.jpg" style="width: 128px; height: 128px;" />
        <h2>Irritable Bowel Syndrome</h2>

        <p>IBS is the most common diagnosis in clinical gastroenterology. It is estimated that approximately 10 to 15 percent of the general adult population is affected. AGA offers recommendations about pharmacological therapy for IBS-C (constiptation) and IBS-D (diarrhea).</p>
    </div>

    <div class="long">
        <div>
            <h3>Drug Management</h3>

            <p>Irritable Bowel Syndrome: Guidline on Pharmacological Management</p>

            <p><a href="/guidelines/2014/09/14/pharmacological-management-of-ibs" target="_top">Guideline</a> | <a href="http://www.gastrojournal.org/article/S0016-5085(14)01090-7/fulltext" target="_top">Technical Review</a></p>
        </div>
    </div>
    <!-- *-------===== Functional GI Disorders Start =====-------* -->

    <div class="short"><img src="/patient-care/conditions-diseases/Function_GI_Disorders.jpg" style="width: 128px; height: 128px;" />
        <h2>Functional GI Disorders</h2>

        <p>Functional GI disorders affect patient quality of life. AGA offers a growing portfolio of resources to help care for patients with these disorders.</p>
    </div>

    <div class="long">
        <div>
            <h3>Constipation</h3>

            <p>Constipation</p>

            <p><a href="/guidelines/2014/03/04/constipation" target="_top">Guideline</a> | <a href="http://www.gastrojournal.org/article/S0016-5085(12)01544-2/fulltext" target="_top">Technical Review</a> | <a href="http://campaigns.gastro.org/algorithms/constipation/" target="_top">Clinical Decision Support Tool</a></p>
        </div>

        <div>
            <h3>Upper-GI Biopsy to Evaluate Dyspepsia</h3>

            <p>Expected October 2015</p>

            <p>&nbsp;</p>
        </div>

        <div>
            <h3>Acute Diverticulitis</h3>

            <p>Expected November 2015</p>

            <p>&nbsp;</p>
        </div>

        <div>
            <h3>Evaluation of Chronic Diarrhea</h3>

            <p>Expected Spring 2017</p>

            <p>&nbsp;</p>
        </div>
    </div>
    <!-- *-------===== Obesity Start =====-------* -->

    <!--<div class="short"><img src="/patient-care/conditions-diseases/Obesity.jpg" style="width: 128px; height: 128px;" />-->
        <!--<h2>Obesity</h2>-->

        <!--<p>As the obesity epidemic grows, AGA will offer tools for gastroenterologists to care for patients after bariatric surgery.</p>-->
    <!--</div>-->

    <!--<div class="long">-->
        <!--<div>-->
            <!--<h3>Post-Surgery Management</h3>-->

            <!--<p>Expected spring 2016</p>-->

            <!--<p>&nbsp;</p>-->
        <!--</div>-->
    <!--</div>-->
    <!-- *-------===== Future Guidelines Start (UPCOMING GUIDELINES) =====-------* -->

    <div style="clear:both;">&nbsp;</div>

    <div class="hmargin">
        <h1>Upcoming Guidelines</h1>

        <p>Clinical practice guidelines are developed under the aegis of the AGA Institute Clinical Guideline Committee and provide preferred approaches to specific medical problems or issues.</p>

        <table>
            <thead>
            <tr>
                <th>Guideline Topic</th>
                <th>Expected Publication Date</th>
            </tr>
            </thead>
            <tbody>
            <tr>
                <td>Role of Upper-GI Biopsy to Evaluate Dyspepsia in the Absence of Mucosal Lesions</td>
                <td class="center">October 2015</td>
            </tr>
            <tr>
                <td>Management of Patients with Suspected Hereditary Colorectal Cancer</td>
                <td class="center">September 2015</td>
            </tr>
            <tr>
                <td>Management of Acute Diverticulitis</td>
                <td class="center">Fall 2015</td>
            </tr>
            <tr>
                <td>Medical Management of Microscopic Colitis</td>
                <td class="center">December 2015</td>
            </tr>
            <tr>
                <td>Management of Acute Liver Failure</td>
                <td class="center">Fall 2016</td>
            </tr>
            <tr>
                <td>Role of Elastography in the Evaluation of Liver Fibrosis</td>
                <td class="center">Fall 2016</td>
            </tr>
            <tr>
                <td>Management of Crohn&#39;s Disease After Surgical Resection</td>
                <td class="center">Early 2017</td>
            </tr>
            <tr>
                <td>Evaluation of Chronic Diarrhea</td>
                <td class="center">Early 2017</td>
            </tr>
            </tbody>
        </table>
    </div>
</div>
